1. Methyl Ethyl Ketone
2. Cyclohexanone
3. Isopropyl alcohol
4. Denatured Alcohol
5. Acetone
6. Urethane
7. Polyvinyl Chloride (Liquid vinyl) This ingredient was used in all medical devices
      made at Edwards Lab, from tubing to gel.
8. Lacquer Thinner
9. Ethyl Acetate
10. Epoxy Resin
11. Epoxy Hardener - both 10 & 11 are chemically known as glycosides Ether
of Bisphenol A.
12. Amine
13. Printing Ink
14. Toluene
15. Dichloromethan (Methylene Chloride) This breaks down in the body so blood cannot
carry oxygen: Metabolizes carbon monoxide poisoning. Causes CSN depression.
16. Freon
17. Silicone
18. Flux
19. Solder
20. Metal cleaning Acid
21. Lofol (Formaldehyde)
22. Talcum Powder
23. Color Pigments as Release Agents
24. Oakite (Cleaning Solvent)
25. Eastman 910 glue (Cyanoacyrylates)
26. Ethylene Oxide (ETO)
27. Carbon Black
28. Xylene
29. Hexone
30. Hexanone2
31. Thixon-OSN-2
32. Antioxidant (Rubber)
33. Acid stearic
34. Zinc Oxide
35. Naptha (Rubber Solvent)
36. Phenol
37. Benzene - Known Carcinogen!!!!!
KNOWN TO CAUSE IMMUNE DISEASE!!!!!! 
 
Abbreviations:

ACGIH -American Conference of Governmental
Industrial Hygienists
ATSDR -Agency for Toxic Substances and Disease
Registry
CDC -Center for Disease Control
IDLH -Immediately dangerous to life and
health. Unless otherwise noted NIOSH
IDLH data is used.
EPA -Environmental Protection Agency
LOAEL -Lowest observable adverse effects level
MG/M3 -Milligrams per cubic meter
MRL -Minimal risk level (non-cancer)
NAS -National Academy of Science
NE -No evidence could be found for the existence of an IDLH
NIOSH -National Institute for Occupational Safety and Health
NOAEL -No observable adverse effects level
NRC -National Research Council
OSHA -Occupational Safety and Health Administration
OTS -Office of Toxic Substances
PEL -Permissible exposure level
PP/S -Personal protective equipment and/or sanitary measures required
for PEL exposure
PPB -Part (s) per billion
PPM -Part (s) per million
REL -Recommended exposure level
TLV -Threshold Value Limits
TN -Trade Name
UG/KG -Microgram per kilogram
UG/DL -Microgram per deciliter
Unknown -Lack of data

Notice: This material may be protected
by copyright law (title 17 U.S.code)

 

No information on numbers 11, 12, 18, 22, 24, 25, 25, 30, 31, and 33


1. 2-BUTANONE:
TN/synonyms: Ethyl ketone. MEK, Methyl acetone, Methyl ethyl ketone.
OSHAP PEL: 200 ppm - 8 hr/day-40hr/wk - PP/S
590 mg/m3 - 8 hr/day-40hr/wk-PP/S
300 ppm - exposure not to exceed 15 min
885 mg/m3 - exposure not to exceed 15 min
ATSDR MRL: 0.1 ppm - Ihalation, less than 15 days
IDLH: 3,000 ppm
symptoms: Eye, nasal, throat, and upper respiratory ittitation; Headaches;
Weakness; Lightheadedness; Dizziness; Vomiting; Numbness of extremities;
Muscle weakness; Nausea; Loss of coordination; Respiratory system effects;
Temporary blindness;
Fatigue; Nerve inflammation behind the eyes. Suspected of causing
Developmental effects.
End-point Targets: Central nervous system, Lungs.
Potentiation: In combination with other solvents it becomes a very
hazardous neurotoxin.
Synergiatic effect; Off-gasses formaldehyde when burned
Note: Research suggests that humans are more sensitive than other species
tested.
Classification: Organic solvent (Ketone compound).
2. CYCLOHEXANONE;
TN/synonms: Cyclohexyl ketone, Pimelic ketone.
PSHA PEL: 25 ppm - 8 hr/day-40hr/wk - PP/S
100mg/m3 - 8 hr/day-40hr/wk - PP/S
IDLH: 5,000 ppm
Symptoms; Eye and mucus membrane irritation, Headaches, Unconsciousness due
to narcotic effects. Coma, Dermatitis
Suspected of causing Birth defects; Reproductive effects; Developmental
effects;
Neonatal lethality; Tearing; Weight loss; Lethargy; Unexpanded fetal lungs
at birth;
Pulmonary damage, edema, and hemorraging; Intestinal congestion
Incoordination; Tremors; Hypothermia.
End-point Targets; Respiratory system, Eyes, Skin, Central nervous system
Classification; Organic solvent (Ketone compound).
Note: Neurotoxin.
3. ISOBUTYL ALCOHOL:
TN/Synonyms: IBA, Isobutanal, Isopropylcarbinol, 2-Methyl-1-propanol.
OSHA PEL: 50 ppm - 8hr/day040hr/wk - PP/S
150 mg/m3 - 8 hr/day-40hr/wk - PP/S
IDLH: 8,000 ppm
Symptoms; Eye, nasal, throat, and skin irritation; Cardiac arrhythmias and
failure;
Central nervous system depression; Chemical sensitivity; Coma: confusion;
Cough;
Cracking skin; Death; Delirium; Dermatitis; Diarrhea; Drowsiness;
Gastrointestinal
hemorrhages; Giddiness; Glucose in urine; Headaches; Impaired performance;
Incoordination; Kidney damage; Labored or difficulty breathing; Liver
damage;
Muscle weakness; Nausea; Pulmonary edema; Respiratory failure; Vertigo;
Vomiting.
Suspected of causing Cancer.
End-point Targets; Eyes, Skin, Respiratory system.
4. ALCOHOLS, DENATURED
Acetaldehyde; n-Butyl alcohol; sec-Butyl alcohol; Crotonaldehyde;
Ethanol; n-Hexane; Pyridine; 1,1,2,2,-Tetrachloroethane; and Zinc chloride.
5. ACETONE:
TN/synonyms: Dimethyl ketone, Ketone propane, Propanone, 2-Propanone,
beta-
Ketopropane, Methyl ketone.
NIOSH REL: 250 ppm - 10hr/day-40hr/wk
590 mg/m3 - 10hr/day-40hr/wk
OSHA PEL: 750 - 8hr/day-40hr/wk - PP/S
1,800 mg/m3 - 8 hr/day-40hr/wk - PP/S
1,000 ppm - not to exceed 15 min
2,400 mg/m3 - not to exceed 15 min
IDLH 1,000 ppm
Symptoms; Eye, nasal, and throat irritation; Belligerence; Blood poisoning;
Alcoholic psychosis; Boastfulness; Bronchitis; Circulatory failure; Cold,
pale skin; Coma; Collapse; Conjunctivitis; Convulsions; Death; Defatting
dermatitis; Dilated pupils; Dizziness; Double vision; Drowsiness; Emotional
liability; Exhilaration; Flushed face; Gastritis; Gastroduodenitis;
Headaches; Hearing loss; Heart rate over 100 beats per minute; Hypothermia;
Impaired or absent tendon reflexes; Incontinence; Incoordination; Increased
susceptibility to infection; Inflammation of airway, stomach, and duodenum;
Liver injury; Loss of sensation; Low blood pressure; Nausea; Peripheral
vascular collapse; Pharyngitis; Pneumonia; Profuse sweating; Rapid pulse;
Remorse; Renal lesions; Respiratory failure; Restlessness; Sensory
disturbances; Shock; Slowed reaction time; Slurred speech; Stupor;
Talkativeness; Vertigo' Vomiting blood; Vomiting; Weakness.
Suspected of causing Adverse spermatoginic effects, Low birth weight,
Neonate lethality
End-point Target: Respiratory system, Eyes, Skin.
Classification; Organic solvent (Ketone compound), Polar volatile organic
compounds.
Note: Found in the blood and urine in diabetes and other metabolic
disorders.
Neurotoxin.

 
6. URETHANE:
Aniline, Ethylenediamine, N-Ethylmorpholine, Hydrazine, and Methylene
chloride.

7.VINYL CHLORIDE;
TN/synonyms: Chloroethene, Chloroethylene, Ethylene monochloride,
Monochlorethylene, VC, Vinyl chloride monomer, VCM, 1-Chloroethylene.
NIOSH: Carcinogen at any exposure level. Reduce exposure to lowest reliably
detectable concentration.
OSHA PEL: 1 ppm - 8hr/day-40hr/wk
5ppm - Ceiling limit, 15 min exposure
ATSDR MRL: 0.006 ppm - Inhalation, more than 14 days
ACGIH: Confirmed human carcinogen.
IDLH: NIOSH - Carcinogen
Symptoms: Pulmonary and kidney irritation; Abdominal pains; Abnormal chest
x-rays; Abnormal decrease in blood platelets; Acroosteolysis (dissolution
of the finger tips); Autoimmune responses similar to sclerosis; Benign
uterine growths; Binds to IgG protein; Blockage of blood vessels; Cancer
(central nervous system, respiratory tract, lymphatic and blood); Cyanosis
of extremities; Death; Decreased libido; Decreased respiratory function;
Discomfort upon exposure to dold; Dizziness; Drowsiness; Emphysema;
Euphoria; Gastrointestinal bleeding; Headaches; Impotency; Inhibits blood
clotting; Joint and muscle pain; Liver damage and enlargement; Loss of
consciousness; Menstrual disturbances; Nausea; Numbness; Ovarian
dysfunction, Pallor; Peripheral neurophthy; Pregnant toxemia, Prolapsed
genital organs; Pulmonary fibrosis; Raynaud's phenomenon symptoms (aka
Vinyl chloride disease); Scleroderma-like skin changes; Systemic sclerosis;
Scleroderma; Spontanious abortions Stiff hands; Thickening of blood vessel
walls and skin; Weakness; Autoimmune disease. Suspected of causing Birth
defects, Testicular damage. End-point Targets: Liver, Central nervous
system, Blood Lymphatic system. Additives/Contaminants: Stabilized with
inhibitors such as phenol.
Note; Occupational exposure of males has been associated with increased
rates of spontaneous abortions in their spouses. Neurotoxin.
 
8. LACQUER THINNERS
sec-Butyl acetate, Cumene, and Isobutyl acetate.

9. ETHYL ACETATE:
TN/synonyms: Acetic ester, Acetic ether, Ethyl ester of acetic acid,
Ethyl ethanoate.
OSHA PEL: 400 ppm - 8hr/day-40her/wk - PP/S
1,400 mg/m3 - 8hr/day-40hr/wk - PP/S
IDLH: 10,000ppm
Symptoms: Eye, nasal, throat, and respiratory irritation; Belligerence;
Boastfulness; Cold, painful skin; Coma; Convulsions; Corneal abnormalities;
Death; Dermatitis; Dilated pupils; Double vision; Drowsiness; Emotional
instability; Exhilaration; Flushed face; Gastritis; Headaches; Heart rate
over 100 beats per minute; Hypoglycemia; Hypothermaia; Impaired motor
skills; Impaaired or absent tendon reflexes; Incontinence; Incoordination;
Low blood pressure; Lung, liver, kidney, and heart damage; Nausea; Partial
or complete loss of sensation; Peripheral vascular reaction time; Slowed
respiration; Slurred speech; Stupor; Talkativeness; Unconsciousness due to
narcotic effects; Vertigo; Vomiting; Weakness. Suspected of causing Central
nervous system depression, Death.
End-point Targets: eyes, skin, Respiratory system.
Classificaton; Polar volatile organic compounds.
Note: neurotoxin.

10. EPOXY RESINS:
Diglycidyl ether, Phthalic anhydride, Triethylamine, and Trimellitic
anhydride.

13. PRINTING INKS:
Acetone; Aniline; Benzidine; 2-Butanone; alpha-Chloroacetophenone;
Cyclohexanone; diisobutyl ketone; Dimethylformamide; Ethyl acetate; Ethyl
butyl ketone; Ethylene glycol; n-Heptane; Isoamyl acetate; Isopropyl
acetate; Methyl n-amyl ketone; Methyl cellosolve; 5-Methyl-3-heptanone;
2-Nitropropane; 2-Pentanone; n-diisocyanate; 1/1/1/-Trichloroethane;
Triethylamine; and Trimellitic anhydride.

14. TOLUENE:

TN/synonyms: Methyl benzene, Methyl benzol, Phenyl methane, Toluol.
OSHA PEL: 100 ppm - 8 hr/day-40hr/wk - PP/S
375 mg/m3 8 hr/day-40hr/wk - PP/S
150 ppm - exposure not to exceed 15 min
560 mg/m3 exposure not to exceed 15 min
ATSDR MRL: 4 ppm - Inhalation, less than 15 days
1 ppm - Inhalation, more than 14 days
IDLH: 2,000 ppm
Symptoms Eye, skin, and respiratory irritation; Abdominal pain; Anemia:
Birth defects; Central nervous system dysfunction and depression: Coma:
Confusion: Death: Delerium: Dermatitis: Dilated pupils: Dizziness:
Drowsiness: Dry skin: Emotional instability; Enlarged liver; Euphoria;
Fatigue: Fetal anomalies and developmental delay: Fetal central nervous
system dysfunction; Hallucinations: Headaches: impaired reaction time,
perception, and motor control; Incoordination: Insomnia; Liver desorders
and injury; Mild to severe toxic brain dysfunction; Muscle fatigue; Nausea;
Nervousness; Neurobehavioral changes; Numbness, tingling, or prickling
sensation; Organic affective syndrome; Psychosis; Tearing, Vertigo; Vision
disturbances; Vomiting; Weakness.
Suspected of causing Blurred vision, Involuntary eye movement, Tremors,
Staggering gait, Abnormal electroencephalogram.
End-point Targets: Central nervous system, Liver, Skin.
Classification: Organic solvent, Polar volatile organic compounds.
Note: Historically established as a neurotoxin.


15. METHYLENE CHLORIDE:
TN/synonyms: Dichloromethane, Methylene dichloride, Narkotil 9tn),
Salaesthin (tn), Solmethine (tn).
NIOSH: Carcinogen at any exposure level. Reduce exposure to lowest possible
level
OSHA PEL: 500 ppm - 8hr/day-40hr/wk - PP/S
1000 ppm - ceiling limit
2000 ppm - 5 min max peak in any 2 hrs
ACGIH: Suspected human carcinogen.
ACGIH TLV: 50 ppm - 8hr/day-40hr/wk
175 mg/m3 - 8 hr/day-40hr/wk
ATSDR MRL: 1.0 ppm - Inhalation, less than 15 days.
0.4 ppm - Inhalation, more than 14 days.
IDLH: 5,000ppm
Symptoms: Eye, nasal, throat, skin irritation; Fatigue; Weakness;
Sleepiness; Lightheadedness; Dizziness: Reduced coordination; Limbs numb
and/or tingling; Nausea; Death; Loss of consciousness; Liver and kidney
damage; Increase in serum bilirubin; Partial or complete loss of sensation;
Decrease in psychomotor skills and behavioral performance. Suspected of
causing Cancer (lung), Low birth weight, Low sperm count, DNA damage,
Genetic mutations, Chromosomal aberrations, Brain damage.
End-point Targets; Skin, Cardiovascular system, Central nervous system.
Note: Does not easily burn.
Classification; Halogenated organic compountd, Polar volatile organic
compounds.
Note: neurotoxin
16. FREON:
Carbon tetrachloride, Dichlorodifluoromethane,
Dichloromonofluoromethane, Dichloromonofluoromethane,
Dichlorotetrafluoroethane, Fluorotrichloromethane, Methyl chloride, and
Trifluorobromomethane.
17. SILICONE
Chlorobenzene; Cresols; Isophorone; Methyl chloride; Stibine;
Tetrachloroethylene; Tin; 1,1,1,-Trichloroethane.

19. SOLDERING MATERIALS;
Antimony, Arsine, Cadmium, Hydrazine, Lead, Silver, Tin, Triethylamine,
and Zinc chloride.

20. METAL CLEANERS:
2-Butoxyethanol; Cyanides; Diacetone alcohol; Ethylene dichloride;
Ethylene glycol; Hydrogen peroxide; Manganese; Methylene chloride; Naphtha;
Oxalic acid; Petroleum distillates; Silver; 1,1,2,2,0Tetrachloroethane; and
Tetrachloroethylene
21. FORMALDEHYDE:
TN/sysnonyms: Quaternium - 15, Methanal, Methyl aldehyde, Methylene oxide,
Formalin, Formaic aldehyde, Formalith, Formol, Fyde, BVF, Morbicid,
Oxymethylene; Oxomethane, Lysoform, Lofol, superlysoform, Fannoform,
Ivalon.
NIOSH: Carcinogen at any exposure level
NIOSH REL: 0.016 ppm - 10hr/day-40hr/wk
0.100 ppm - ceiling limit not to exceed 15 min
OSHA PEL: 1.000 ppm - 8 hr/day-40hr/wk - PP/S
2.000 ppm - exposure not to exceed 15 min
0.500 ppm - requires medical surveillance
NAS: There is no population threshol for irritation effects.
NRC: Fewer than 20% but perhaps more than 10% of the general population
may be suspectible to formaldehyde and may react acutely at any exposure
level.
ACGIH: Suspected human carcinogen.
IDLH: 30 ppm
Symptoms; Eye, nasal, throat, and pulmonary irritation; Acidosis; Acute
sense of smell; Alters tissue proteins; Anemia; Antibodies formation;
Apathy: Blindness; Blood in urine; Blurred vision; Body aches; Bronchial
spasms; Bronchitis; Burns nasal and throat; Cardiac impairment,
palpitations and arrhythmias; Central nervous system depression; Changes in
higher cognitive functions; Chemical sensitivity; Chest pains and
tightness; Chronic vaginitis; Colds; Coma; Conjunctivitis; Constipation;
Convulsions; Corneal erosion; cough; Death; Destruction of red blood cells;
Depression; Dermatitis; Diarrhea; Difficulty concentrating; Disorientation;
Dizziness; DNA damage; Drowsiness Ear aches; Eczema; Emotional upsets;
Ethmoid polypos; Fatigue; Fecal bleeding; Fetal asphyxiation; Flu-like or
cold-like illness; Frequent urination with pain; Gastritis;
Gastrointestinal inflammation; Headaches; Hemolytic anemia; Hemolytic
hematuria; Hoarseness; Hyperactive airway disease; Hyperactivity;
Hypomenstrual syndrome; Immune system sensitizer; Impaired (shsort)
attention span; Impaired capacity to attain attention; Inability or
difficulty swallowing; Inability to recall words and nae=mes; Intestinal
pain; Intrinsic asthma; Irritaability; Jaundice; Joint pains,m aches, and
swelling; Kidney pain; Larynbgeal spasm: Loss of memory; Loss of sense
smell; Loss of taste: Malaise; Menstrual and testicular pain; Menstrual
irregularities; Metallic taste; Muscle spasms and cramps: Nasal congestion,
crusting, and mucosa inflammation; Nausea; Nosebleeds; Numbness and
tingling of the forearms and finger tips: Pale, clammy skin: Partial
laryngeal paralysis: Pneumonia: Post nasal drip: Pulmonary edema; Reduced
body temperature: Retarded speech pattern: Ringing or tingling in the ear:
Schizophrenic-type symptoms; Sensitivity to sound; Shock; Short term memory
loss; Shortness of breath: Skin lesions; Sneezing; Sore throat: Spacey feeling;
Speaking difficulty: Sterility: Swollen glands; Tearing: thirst: Tracheitis:
Tracheobronchitis:Vertigo: Vomiting blood: Vomiting: Wheezing. Suspected
of causing Cancer, Genetic mutations, Chromosomal damage.

End-point Targets: Respiratory system, Eyes, Skin, Central nervous system,
Liver, Kidneys, Gastrointestinal tract, Cardiovascular system. Metabolized
as Formic acid.
Note: Will cross sensitize to formic acid. Comparison of ciliostatic
effects showed formaldehyde to be the most toxic of the aldehydes. EPA
estimates that 15 people in 1 million will get cancer from lifetime
exposure of 1 ppb. Neurotoxin.
23. PIGMENTS
Aniline, Antimony trioxide, Arsenic, barium, Benzidine, Cadmium, Carbon
monoxide, Chromium, Cobalt, Cyanides, Diacetone alcohol, Dibutylphthalate,
Dimethylformamide, Ethyl acrylate, Lead, Mercury, Methyl cellosolve,
Molybdenum, Nickel, p-Nitroaniline, Nitrophenols, Oxalic acid, Phthalic
anhydride, Selenium, Tellurium Titanium dioxide, Tributyl phosphate,
Trimellitic anhydride, Vanadium pentoxide, and Zinc oxide.

26. ETHYLENE OXIDE:
TN?synonyms: Dimethylene oxide; 1,2-Epoxy ethane: Oxirane:
Dihydro-oxirene; Epoxyethane; Ethene oxide; ETP Anprolene (tn)/ Oxyfune
(tn); T-Gas (tn).
NIOSH: Carcinogen at any exposure level.
NIOSH REL:< 0.1ppm - 10hr/day-40hr/wk
0.18 mg/m3 - 10hr/day-40hr/wk
5 ppm - cdeiling limit
9 mg/m3 - 15 min/day
OSHA PEL: 1 ppm - 8hr/day-40hr/wk
5ppm - 15-min Excursion
ACGIH: Suspected human carcinogen.
ATSDR MRL: 0.09 ppm - Inhalation, more than 14 days
IDLH: 800 ppm
Symptoms: Eye, nasal and throat irritation; Bronchitis; Burns skin and
eyes; Cancer (Leukemia, stomach, pancreatic): Cataracts: Chromosomal
aberrations; Cornieal burns; Cyanosis; Decreased sperm coundt; Diarrhea;
Electrcardiogram abnormalities; Emphysema; Frostbite; Headaches; Hodgkin's
disease; Impaired hand/eye coordination; Labored or difficulty breathing;
Memory loss; Nausea; Neuropathy; Numbness, tingling, or prickling
sensation; Peculiar taste; Peripheral neurophathy: Pulmonary edema;
Spontaneous abortion; Vomiting. Suspected of causing Nasal mucosa
inflammation, Epithelial tissue death, Respiratory lesions, Low birth
weight, Neonate lethality, Birth defects, Testicular degeneration,
Convulsions, Liver and kidney damage.
End-point targets: Respiratory system, Central nervous system.
27. CARBON BLACK
TN?sysonyms: Acetylene black, Channel black, Furnace black, Lamp black,
Thermal black.
NIOSH: Carcinogen AT ANY EXPOSURE LEVEL.
OSHA PEL: 3.5 mg/m3 - 8 hr/day-40hr/wk
Symptoms Unknown
Target organ: Unknown
Note: Present in Polycyclic aromatic hydrocarbons.
28. XYLENES:
TN/synonyms: Dimethylbenzene, Eyolol, Methyl toluene, violet 3 (tn).
Isomers:
m-Xylene - 1,2-Dimethylbenezene; 1,3-Xylene; m-Dimethylbenzene:
m-Xyolol: m-Methyltoluene; meta-Xylene.
o-Xylene - 1,2-Dimethylbenezene: 1,2-Xylene; o-Dimethylbenzene;
o-Xyolol; o-Methyltoluene; ortho-Xylene.
p-Xylene - 1,4-"Dimethylbenezene: 1,4-Xylene; p-Dimethylbenzene;
p-Xyolol; p-Methyltoluene: para-Xylene; Scintillar (tn)

ASHA PEL: 100 ppm - 8 hr/day-40hr/wk - PP/S
435 mg/m3 8hr/day-40hr/wk - PP/S
150 ppm - exposure not to exceed 15 min
655 mg/m3 exposure not to exceed 15 min
IDLH: 1,000 ppm
Symptoms: Eye nasal, throat, and respiratory irritation; Abdominal pain;
Abnormal electrocardiograms; Amnesia; Brain hemorrhage; Cardiac
palpitations; confusion; Corneal vacuolization; Death; Dermatitis;
Dizziness; Drowsiness; Epileptic convulsions; Excitement; Fatigue; Gastric
discomfort; Headaches; Impaired ability to work with numbers, balance,
pulmonary function, and reaction times; Labored breathing; Lightheadedness;
Liver and kidney damage; Loss of appetite and patience; Nausea; Pulmonary
congestion, hemorrhaging, edema and damage; Reduced coordination;
Respiratory failure; Short-term memory loss; Staggering gait; Tremors;
Unconsciousness due to narcotic effects; Ventricular fibrillation; Vomiting
Suspected of causing Birth defects: Spontaneous abortions; Cerebral
dysfunction; Blurred vision; Involuntary eye movement
End-point Targets: Central nervous system, Eyes, blood, Skin,
gastrointestinal tract, Liver, Kidneys.
Mixed Xylenes usually contain the three forms of xylenes and 6% to 15%
ethylbenzene.
Classification: Organic solvent, Polar volatile organic compounds.
Note: Neurotoxin.
29. Hexone:
TN/synonyms: Isobutyl Methyl ketone, Methyl isobutyl ketone, 4-Methyl
2-pentanone,
MIBK
OSHA PEL: 50 ppm - 8hr/day-40herwk - PP/S
205 mg/m3 - 8hr/day-40hr/wk - PP/S
75 ppm - exposure not to exceed 15 min
300 mg/m3 - exposure not to exceed 15 min
IDLH: 3,000 ppm
Symptoms: Eye, nasal, throat and mucus membrane irritation; Headaches;
Nausea; Vomiting; Loss of appetite; Diarrhea; Drowsiness: Dizziness: Loss
of balance; Weakness: Stomach pain; Sore throat; Fatigue; Insomnia:
intestinal pain: Enlarged liver; Colitis; Unconsciousness due to narcotic
effects; Coma; Dermatitis: Central nervous system depression,
Lightheadedness; Incoordination; somnolence; Heartburn; Central nervous
system impairment.
End-point Targets: Respiratory system, Eyes, Skin, Central nervous system.
Note: Occupational tolerance seems to develop during the work week but is
lost over the weekend. some adverse effects have been noted below ASHA PEL.
Classification: Organic solvent (Ketone compound).

32. RUBBER
Acetic acid; Acetone; Acetonitrile; Acrylonitrile; Aluminum; Ammonia;
sec-Amyl acetate; Aniline; Antimony trioxide; Asbestos; Barium; Benzene;
Benzyl chloride; 1,3-Butadiene; n-Butyl alcohol; Butylamine; Calcium oxide;
Camphor; Carbon disulfide; Chlorinated diphenyl; Chlorobenzene; Chloroform;
beta-Chloroprene; Chromium; Crotonaldehyde; Decaborane; Dibornane;
o-Dichlorobenzene; 1,2-Dichloroethylene; Diethylamine; Diglycidyl ether;
Dimethylamine Dimethylphthalate; Ethanolamine; Ethylene dichloride;
N-Ethylmorpholine; Formaldehyde; Furfural; Hexachloroethane; Hydroquinone;
Isopropylamine; Magnesium oxide; Mesityl oxide; Mica; Molybdenum;
Morpholine; p-Nitrochlorobenzene; Nitrophenols; n-Nitrosodimethylamine;
Oxalic acid; Paraldehyde; p-Phenylene diamine; Phthalic anhydride;
Polychlorinated biphenyls; Propylene dichloride; Propylene imine; Pyridine;
Quinone; Selenium; Styrene; Sulfur monochloride; Tellurium;
1,1,2,2-Tetrachloroethane; Tetrahydrofuran; Titanium dioxide; o-Toluidine;
Toluene; 1,1,2-Trichloroethane; Triethylamine; Vanadium
pentoxide; Xylenes' Zinc chloride; and Zinc oxide.
34. ZINC OXIDE:


OSHA PEL: 5mg/m3 - 8hr/day - 40hr/wk
10mg/m3 - exposure not to exceed 15 min
IDLH: NE
Symptoms: Sweet or metallic taste, Dry throat, Cough, Chills, Fever, Tight
chest, Labored or difficult breathing, Rales, Reduced pulmonary function,
Blurred vision, Muscle cramps and pain, Lower back pain, Nausea, Vomiting,
Fatigue, Lassitude, Malaise, Metal fume fever, Dermatitis, Boils,
Conjunctivitis, Gastrointestinal disturbances, Pneumonia, Increase in
leukocytes in the blood, Liver dysfunction, Gastrointestinal inflammation,
Yawning, Weakness, Body aches, Headaches.
End-point Targets: Respiratory system, Skin.
Note: In one report, symptoms didn't appear until after 6 months of
occupational exposure.


35. NAPTHA:
TN/synonyms: Crude solvent coal tar naptha, High solvent naptha.
OSHA PEL: 100 ppm - 8hr/day - 40hr/wk - PP/S
400 mg/m3 - 8hr/day - 40hr/wk - PP/S
IDLH: 10,000 ppm
Symptoms: Eye, nasal, throat, and skin irritation; Lightheadedness;
Headaches; Loss of appetite; Dizziness; Indigestion; Nausea; Insomnia
End-point Targets: Respiratory system, Eyes, Skin
Component: Cumene
Classification: Organic solvent (Refined Petroleum)

36. PHENOL
TN/synonyms: Carbolic acid, Hydroxybenzene, Monohydroxy benzene, Phenyl
alcohol, Phenyl hydroxide.
NIOSH REL: 5 ppm - 10her/day - 40hr/wk
19 mg/m3 - 10hr/day - 40hr/wk
15.6ppm - ceiling limit, 15 min exposure
60 mg/m3 - ceiling limit, 15 min exposure
OSHA PEL: 5 ppm - 8hr/day - 40hr/wk - PP/S
19 mg/m3 8hr/day - 40hr/wk - PP/S
HSDB TOXS; Some individuals may be hypersensitive with lethality or serious
effects at very low exposures
IDLH: 250 ppm
Symptoms: Eye, nasal and throat irritation; Abdominal pain; Cardiac
arrhythmias and failure; Cardiovascular collapse; Chemical odor on breath;
Chromosomal aberrations and damage; Cold sweats: Collapse: Coma: Confusion:
Convulsions; Cyanosis; Dark pigmentation of the ligaments, cartilage, and
fibrous tissue; Dark urine; Dermatitis; Diarrhea; Difficulty swallowing;
Dizziness; Excessive bilirubin in blood; Excitement; Fainting; Frothing at
nose and mouth; Genetic mutations; Granules in red blood cells; Headaches;
Hemoglobin oxidizes to ferric form; Hemolytic anemia; Hypothermia; Liver,
kidney, and heart damage; Loss of appetite; Low blood pressure Muscle
aches, pain, and twitching; Nausea; Pallor; Profuse sweating; Pulmonaary
edema; Renal infufficiency; Ringing or tingling in the ear; Shallow
respiration; Shock; Skin burnns; Spontaneous abortions; Tremors;
Unconsciousness; Vomiting: Weak, irregular pulse; Weakness; Weight loss.
End-point Targets: Liver, Kidneys, Skin
Derivative of Benzene.
Note: historically established as a neurotoxin.
37. BENZENE
TN/synonyms: Benzol, Benzole, Annulene, Benzeen Phenyl hydride, Coal
naptha, Cyclohexatriene, Fenzen, Phene, Pyrobenzol, Pyrobenzole, Polystream
tn) Benzol 90 (tn).
NIOSH: Carcinogen at any exposure level.
NIOSH REL: 0/1 ppm - 10hr/day-40hr/wk
1 ppm - exposure not to exceed 15 min
OSHA PEL: 1 ppm - 8hr/day - 40hr/wk - PP?S
5 ppm - exposure not to exceed 15 min
ACGIH: Suspected human carcinogen.
TSDR MRL: .001 ppm - inhalation, less than 15 days.
IDLH: 3,000 ppm
Symptoms; Eye, nasal, and respiratory system irritation; Eye, skin, DNA,
immune system, and chromosomal damage; Abnormal decrease in white blood
cells; Anemia; Antibody formation, Aplastic anemia: Asphyxia; Blood
diseases; Blurred vision; Bone marrow depression, Bronchitis; Cancer
(leukemia); Cardiac collapse; Central nervous system depression; Cerebral
swelling; Congestive gastritis; Convulsions; Death; Decreased antibodies,
leukocytes, erythrocytes, and platelets; Decreased coordination; Delirium;
Dermatitis; Dizziness; Drowsiness; Effects brain catecholamines; Euphoria;
Fatigue; Gastritis; Giddiness; Granular tracheitis; Headaches; Impaired
judgement; Kidney congestion; Laryngitis; Lassitude: Leukocyte chromosomal
aberrations; Lightheadedness; Loss of appetite; Loss of balance; Menstral
pain and disorders; Nausea; Nervousness; Non-lymphocytic leukemia; Ovarian
atrophy; Pallor; Paralysis; Premature births; Pulmonary hemorrhage; Pyloric
strictures; Underdevelopment of organs or body; Vertigo; Vomiting;
Weakness. Suspected of causing Birth defects.
End-point Targets: Blood, Central nervous system, bone marrow, Skin, Eyes,
Respiratory system.
Metabolites: Benzene oxide oxepin, Muconic acid, Phenyl Mercapturic acid,
Pre-phenyl mercapturic acid, Benzene oxide, Benzene glycol, Muconaldehyde,
Benzoquinone, Hydroquinone, Phenol, Catechol, Trihydroxy benzene,
Glucuronide, Sulfate.
Classification: Organic solvent.
Note: Historically established as a neurotoxin.
 

References. . .
4. Denatured alcohols, 6. Urethane, 8. Lacquer thinners, 10. Epoxy
resin, 13. Printing inks, 16. Freon, 17. Silicone 19. Soldering materials,
20. Metal cleaners, 23. Pigments, and 32. Rubber.
Wilson, C.: Chemical Exposure and Human Health: A Reference to
314 Chemicals, with a Guide to Symptoms, and a Directory of Organizations,
1993) McLFarland & Company, Jefferson, NC.

1. 2-Butanone:
U.S. Department of Health and Human Services, Public Health Service,
Centers for Disease Control, National Institute for Occupational Safety and
Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S.
Government Printing Office, Washington, D.C.

U.S. Department of Health
and Human Services, Public Health Service, Agency for Toxic Substances
and Disease Registry, "Toxicology Profile for 2-Butanone," July 1992,
Syracuse Research Corporation.

U.S. Department of Health and Human Services, Public Health Service,
Centers for Disease Control, National Institute for Occupational Safety and
Health, "NIOSH Current Intelligence Bulletin 48 - Organic Solvent
Neurotoxicity, "March 31, 1987.

U.S. Department of Health and Human Services, Public Health Service,
Centers for Disease Control, National Institute for Occupational Safety and
Health, "Regulations, Recommendations and Assessments Extracted from RTECS:
A Subfile of the Registry of Toxic Effects fof Chemical Substances, "
September 1986, U.S. Government Printing Office

U.S. Environmental Protection Agency, Air Quality Planning and

Last edited on Fri May 5th, 2006 12:58 am by Beth

My Personal Story:
http://www.ToxicBreastImplants.org

Clipart for Crafts and Scrapbooking:
http://www.TheClipartCorner.com

My Personal Story:
http://www.ToxicBreastImplants.org

Clipart for Crafts and Scrapbooking:
http://www.TheClipartCorner.com

My Personal Story:
http://www.ToxicBreastImplants.org

Clipart for Crafts and Scrapbooking:
http://www.TheClipartCorner.com

My Personal Story:
http://www.ToxicBreastImplants.org

Clipart for Crafts and Scrapbooking:
http://www.TheClipartCorner.com

YEP, I'M MAD!!!! 

My Personal Story:
http://www.ToxicBreastImplants.org

Clipart for Crafts and Scrapbooking:
http://www.TheClipartCorner.com

My Personal Story:
http://www.ToxicBreastImplants.org

Clipart for Crafts and Scrapbooking:
http://www.TheClipartCorner.com